A study on a drug used to treat COVID-19 patients by a nephrologist and a professor of the Indian Institute of Technology Madras has been published in a peer-reviewed journal Nature. The article, ”An open label randomised clinical trial of indomethacin for mild and moderate hospitalised Covid-19 patients” was published on April 19.
The study used a nonsteroidal anti-inflammatory drug indomethacin to treat over 200 persons with mild and moderate COVID-19 symptoms during the first and second wave.
Rajan Ravichandran, an adjunct faculty in the institute and director of nephrology at MIOT Hospital, and R. Krishna Kumar, institute professor, conducted the study.